1Krishna Institute of Medical Science "Deemed to be University", Karad - 415539, Maharashtra
2Rajarambapu College of Pharmacy, Kasegaon, District - Sangli, Maharashtra, 415404, India
3Department of Pharmaceutical Sciences and Technology, Birla Institute of TechnologyMesra, Ranchi, (Jharkhand) 835215India
4Dept. of Pharmaceutical Chemistry, Anandi Pharmacy College, Kalambe tarf Kale, Tal - Karveer, Dist- Kolhapur, 416205
5Principal, Seth Govind Raghunath Sable College of Pharmacy, Saswad, Dist - Pune, Tal - Purandar, 412301
*Corresponding Author E-mail: prithvirajpatil87@gmail.com
Online Published on 10 October, 2023.
Main aim of study is to investigate the Rubiadin effects in mice model of chronic inflammation and pain. Complete Freund’s adjuvant (CFA) inflammatory model was used for investigation of chronic hypersensitivity. Prior CFA inflammation, Von Frey filaments and acetone induced cold sensitivity test was used to evaluate hypersensitivity, respectively. The paw edema was measured using digital plethysmometer. Intraperitoneally administered Rubiadin (100 and 200mg/kg) prior testing reduced CFA induced mechanical hypersensitivity. Rubiadin reduces evoked acetone cold hypersensitivity. Compared with vehicle, Rubiadin reduces paw edema too. Rubiadin reduced mechanical hypersensitivity significantly when administered two times a day from first to fifth day and from ninth to tenth day. In conclusion study revealed Rubiadin anti-nociceptive activity in chronic pain and also might be potential for effective management of pain.
Rubiadin, CFA, Antinociceptive activity